Liu V, Hanson E, Owens J, Hopkin R, Shillington A
Brain Behav. 2025; 15(2):e70276.
PMID: 39915227
PMC: 11802274.
DOI: 10.1002/brb3.70276.
Gandhi S, Sweeney G, Perry C
Biomedicines. 2024; 12(7).
PMID: 39061981
PMC: 11274162.
DOI: 10.3390/biomedicines12071407.
Lowes L, Alfano L, Iammarino M, Reash N, Giblin K, Hu L
PLoS One. 2024; 19(5):e0300700.
PMID: 38753764
PMC: 11098514.
DOI: 10.1371/journal.pone.0300700.
van Dommelen P, van Dijk O, de Wilde J, Verkerk P
Orphanet J Rare Dis. 2024; 19(1):192.
PMID: 38730494
PMC: 11088161.
DOI: 10.1186/s13023-024-03208-8.
McDonald C, Camino E, Escandon R, Finkel R, Fischer R, Flanigan K
J Neuromuscul Dis. 2024; 11(2):499-523.
PMID: 38363616
PMC: 10977441.
DOI: 10.3233/JND-230219.
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective.
Johnston K, Audhya I, Dunne J, Feeny D, Neumann P, Malone D
Appl Health Econ Health Policy. 2024; 22(3):343-352.
PMID: 38253973
PMC: 11021240.
DOI: 10.1007/s40258-023-00869-7.
Title-molecular diagnostics of dystrophinopathies in Sri Lanka towards phenotype predictions: an insight from a South Asian resource limited setting.
Wijekoon N, Gonawala L, Ratnayake P, Liyanage R, Amaratunga D, Hathout Y
Eur J Med Res. 2024; 29(1):37.
PMID: 38195599
PMC: 10775540.
DOI: 10.1186/s40001-023-01600-x.
Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications.
Mercuri E, Pane M, Cicala G, Brogna C, Ciafaloni E
Front Pediatr. 2023; 11:1276144.
PMID: 38027286
PMC: 10667703.
DOI: 10.3389/fped.2023.1276144.
Mutation spectrum analysis of gene in Indonesian Duchenne and Becker muscular dystrophy patients.
Dwianingsih E, Iskandar K, Hapsara S, Ping Liu C, Malueka R, Gunadi
F1000Res. 2023; 11:148.
PMID: 38009102
PMC: 10668572.
DOI: 10.12688/f1000research.73476.3.
Duchenne Muscular Dystrophy from Brain to Muscle: The Role of Brain Dystrophin Isoforms in Motor Functions.
Wijekoon N, Gonawala L, Ratnayake P, Amaratunga D, Hathout Y, Mohan C
J Clin Med. 2023; 12(17).
PMID: 37685704
PMC: 10488491.
DOI: 10.3390/jcm12175637.
Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology.
Wijekoon N, Gonawala L, Ratnayake P, Dissanayaka P, Gunarathne I, Amaratunga D
Heliyon. 2023; 9(8):e18530.
PMID: 37593636
PMC: 10432191.
DOI: 10.1016/j.heliyon.2023.e18530.
Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy.
Audhya I, Rogula B, Szabo S, Feeny D, Bolatova T, Gooch K
Health Qual Life Outcomes. 2023; 21(1):76.
PMID: 37468890
PMC: 10355009.
DOI: 10.1186/s12955-023-02160-8.
A Comprehensive Study of De Novo Mutations on the Protein-Protein Interaction Interfaces Provides New Insights into Developmental Delay.
Maharjan D, Song W, Liu Z, Wang W, Cai W, Chen J
Biomolecules. 2022; 12(11).
PMID: 36358993
PMC: 9687726.
DOI: 10.3390/biom12111643.
Characterizing the Occurrence of Key Clinical Milestones in Duchenne Muscular Dystrophy in the United States Using Real-World Data.
Szabo S, Klimchak A, Qian C, Iannaccone S, Popoff E, Gooch K
J Neuromuscul Dis. 2022; 9(6):689-699.
PMID: 36245384
PMC: 9697036.
DOI: 10.3233/JND-220816.
Walking alone milestone combined reading-frame rule improves early prediction of Duchenne muscular dystrophy.
Ma Y, Zhang W, Chen G, Song L, Wang Y, Yuan R
Front Pediatr. 2022; 10:985878.
PMID: 36034570
PMC: 9417149.
DOI: 10.3389/fped.2022.985878.
Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI).
Szabo S, Audhya I, Rogula B, Feeny D, Gooch K
Health Qual Life Outcomes. 2022; 20(1):93.
PMID: 35690783
PMC: 9188127.
DOI: 10.1186/s12955-022-02001-0.
Characterizing demographics, comorbidities, and costs of care among populations with Duchenne muscular dystrophy with Medicaid and commercial coverage.
Klimchak A, Szabo S, Qian C, Popoff E, Iannaccone S, Gooch K
J Manag Care Spec Pharm. 2021; 27(10):1426-1437.
PMID: 34595954
PMC: 10391028.
DOI: 10.18553/jmcp.2021.27.10.1426.
The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review.
Szabo S, Salhany R, Deighton A, Harwood M, Mah J, Gooch K
Orphanet J Rare Dis. 2021; 16(1):237.
PMID: 34022943
PMC: 8141220.
DOI: 10.1186/s13023-021-01862-w.
cerebellar circuit function is disrupted in an mouse model of Duchenne muscular dystrophy.
Stay T, Miterko L, Arancillo M, Lin T, Sillitoe R
Dis Model Mech. 2019; 13(2).
PMID: 31704708
PMC: 6906634.
DOI: 10.1242/dmm.040840.
A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy.
Al-Zaidy S, Lloyd-Puryear M, Kennedy A, Lopez V, Mendell J
Int J Neonatal Screen. 2019; 3(2):8.
PMID: 31588416
PMC: 6777346.
DOI: 10.3390/ijns3020008.